A Agilent Technologies Inc.

Agilent Brings Great Science to Life at Analytica 2024

Agilent Technologies Inc. (NYSE: A) today announced its participation in Analytica 2024, where it will unveil its latest innovations and transformative workflows. Analytica, the premier international trade fair for laboratory technology, analysis, and biotechnology, is scheduled to take place from April 9 to 12 in Munich, Germany.

Visit Agilent at Hall A2, Booth 201, to learn about recently introduced products and solutions enabling key workflows that are revolutionizing laboratories across industries including pharma and biopharma, food and environment, chemical and energy, advanced materials, and molecular biology and cell analysis. Agilent technical experts will be available to share insights into these latest innovations and intuitive workflows.

  • Advanced Dilution System (ADS 2)

    Agilent’s newly launched Agilent ADS 2 is an intelligent autodilutor that seamlessly integrates with Agilent autosamplers, ICP-OES (inductively coupled plasma optical emission spectrometry), or ICP-MS (inductively coupled plasma mass spectrometry) instruments. Combined with cutting-edge software, ADS 2 provides customers with a fully integrated automation workflow solution.
  • BioTek Cytation C10 Confocal Imaging Reader

    Visit the Agilent booth for an exclusive first look at the upgraded BioTek Cytation C10 system, now equipped with water immersion and confocal spinning-disk technologies. These enhancements improve image quality, minimize deleterious effects on live-cell samples, and enhance clarity for thicker samples like tissues and 3-D spheroids.
  • 1290 Infinity II Bio Online LC Solution

    The Agilent 1290 Infinity II Bio Online LC Solution will be showcased alongside the MAST aseptic sampling system and Bioreactors from Merck KGaA, Darmstadt, Germany. This powerful combination demonstrates versatility and applicability across upstream and downstream bioprocessing applications.
  • ProteoAnalyzer

    The ProteoAnalyzer is an automated capillary electrophoresis instrument designed for assessing both reduced and non-reduced protein samples. Its streamlined workflow enhances efficiency and reliability, making protein quality control a breeze.

Agilent will also host several meet-and-greet specialist sessions in the booth.

  • Tuesday, 9 April, 4:00--5:00 pm Advanced Materials, and Energy and Chemicals Pods: Battery, Semiconductors, Alternative Energies.
  • Wednesday, 10 April, 4:00—5:00 pm Biopharma Pod: Oligo Analysis, online LC/PAT, Proteoanalyzer.
  • Thursday, 11 April, 4:00—5:00 pm Food & Environmental, and Pharma Pods: Dissolving Boundaries, Unmasking PFAS and Identifying Raw materials.

Agilent subject matter experts will also speak throughout the week at forum sessions. To learn more about Agilent’s complete activities at Analytica 2024 . Join us as we bring Great Science to Life!

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at . To receive the latest Agilent news, please subscribe to the Agilent . Follow Agilent on and .

EN
04/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

Agilent Technologies, Inc.: Key facts and statistics - fiscal 2025

A summary company profile, detailing Agilent Technologies, Inc.’s business operations and financial highlights.

Agilent Technologies, Inc. - October 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Agilent Technologies, Inc.: Update to credit analysis

Our credit view of this issuer reflects its low financial leverage, against its high proportion of revenue from costly equipment sales, which has exposure to cyclical demand fluctuations

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Agilent Technologies, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 11 December 2025 in which we reassessed the appropriateness of the ratings in th...

Agilent Technologies Inc: 1 director

A director at Agilent Technologies Inc sold 2,600 shares at 149.812USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch